Nanovista is developing novel, multi-modality imaging agents for oncology. Nanovista is enabling surgical oncologists with tools to visualize tumours in real-time during surgery with the goal of improving cancer surgery outcomes. The CF800 liposomal imaging agent accumulates specifically at the tumour boundary with healthy tissue and enables the precise visualization of multiple solid tumour types using existing operating room equipment with CT and near-infrared spectrum imaging capabilities.

Event details

Date: September 21 - 23, 2022

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


10 in total